Department of Hand and Plastic Surgery, The 2nd Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, No. 109, Xueyuan West Road, Wenzhou, Zhejiang 325027, China.
Department of Dermatology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, No. 75, Jinxiu Road, Wenzhou, Zhejiang 325027, China.
Mediators Inflamm. 2014;2014:463928. doi: 10.1155/2014/463928. Epub 2014 May 11.
IL-23/IL-17 axis has been identified as major factor involved in the pathogenesis of several autoimmune diseases; yet its pathogenetic role in pemphigus vulgaris (PV) remains controversial. The aim of this research was to investigate the potential role of IL-23/IL-17 axis in the immunopathogenesis of PV, and correlation between IL-23+ cells and IL-17+ cells was also evaluated. For this purpose, ten patients with PV, three patients with pemphigus foliaceus (PF), and six healthy individuals were allocated to this research. The lesional skin biopsy specimens were obtained before treatment. Then immunofluorescence staining was performed to analyze the expression of IL-23 and IL-17 in the PV/PF patients and the healthy individuals. The results showed that the numbers of IL-23+ and IL-17+ cells were significantly higher in PV lesions, compared to PF lesions and normal control skins, respectively (all P < 0.05). Moreover, the correlation between IL-23+ cells and IL-17+ cells was significant (r = 0.7546; P < 0.05). Taken together, our results provided evidence that the IL-23/IL-17 axis may play a crucial role in the immunopathogenesis of PV and may serve as novel therapeutic target for PV.
IL-23/IL-17 轴已被确定为参与几种自身免疫性疾病发病机制的主要因素;然而,其在寻常型天疱疮(PV)中的发病机制作用仍存在争议。本研究旨在探讨 IL-23/IL-17 轴在 PV 免疫发病机制中的潜在作用,并评估 IL-23+细胞和 IL-17+细胞之间的相关性。为此,将 10 名 PV 患者、3 名类天疱疮患者和 6 名健康个体纳入本研究。在治疗前获得皮损皮肤活检标本。然后进行免疫荧光染色,以分析 PV/PF 患者和健康个体中 IL-23 和 IL-17 的表达。结果表明,与 PF 皮损和正常对照皮肤相比,PV 皮损中 IL-23+和 IL-17+细胞的数量明显更高(均 P < 0.05)。此外,IL-23+细胞和 IL-17+细胞之间存在显著相关性(r = 0.7546;P < 0.05)。总之,我们的研究结果提供了证据表明,IL-23/IL-17 轴可能在 PV 的免疫发病机制中发挥关键作用,并且可能成为 PV 的新型治疗靶点。